Industry

From Molecule to Market,
Decisions Backed by Data

Pharma and life sciences run on high-stakes, evidence-led decisions under tight regulatory scrutiny. We turn fragmented R&D, manufacturing and commercial data into traceable, decision-ready insight.

In pharma and life sciences, the cost of a wrong call is measured in years and millions, and every number may need to stand up to a regulator. Data is rich but scattered across discovery, trials, manufacturing and commercial systems. We unify and govern it, with traceability built in.

Industry challenges

The pressures you operate under

The decisions and constraints that shape life-sciences analytics.

01

R&D visibility

Hard to see progress, cost and risk across a complex discovery and development pipeline.

02

Regulatory sensitivity

Numbers and processes that must be defensible, auditable and compliant.

03

Portfolio decisions

High-stakes go / no-go and investment calls that demand strong evidence.

04

Data traceability

A need to know where every figure came from, across systems and time.

Use cases

Where analytics earns its place

Representative applications across the value chain.

01

Pipeline & trial visibility

Track progress, cost and risk across discovery, development and trials in one view.

02

Manufacturing & quality

Connect batch, quality and supply data to keep production reliable and compliant.

03

Commercial analytics

Bring launch, channel and demand insight together to support commercial decisions.

Proof

Why teams choose KEPLER

Built for regulated industries

We design with traceability, governance and auditability in mind, because in life sciences the evidence has to hold up.

Build-and-implement, not just presentations

The same people who scope the work deliver it, and stay accountable for output that goes live and gets used.

Proven on real engagements

See anonymized client outcomes across supply chain, procurement, cost and forecasting. View case studies →

How we work

A governed life-sciences data platform

Scattered signal becomes traceable, decision-ready insight.

01

Unify

R&D, manufacturing and commercial data is brought into a governed platform.

02

Trace

Lineage and governance make every figure defensible and auditable.

03

Model

Portfolio, quality and demand models surface the patterns that drive decisions.

04

Decide

Leaders act on traceable, regulatory-aware insight from molecule to market.

FAQ

Common questions

How do you handle regulatory and traceability requirements?
Governance and data lineage are designed in from the start, so figures are auditable and processes defensible — not bolted on afterwards.
Can you work across R&D, manufacturing and commercial data?
Yes. Unifying those fragmented domains into one governed, traceable view is central to what we do here.
How quickly can we see value given our complexity?
We start with the highest-value decision area and deliver visibility there first, rather than waiting to model the entire estate.
Do we need a finished data platform first?
No. We can build the traceable data foundation and the analytics together, sequenced to show value early.
Example analytics

Where analytics typically applies

Representative analytics we bring to pharma & life sciences.

  • Demand forecasting and supply planning
  • Manufacturing and batch-quality analytics
  • Cold-chain and distribution analytics
  • R&D and clinical-trial progress analytics
  • Procurement and supplier-risk analytics
  • Regulatory and compliance reporting

Book a 60-minute working session

Bring a real decision or dataset — we’ll show you how KEPLER would approach it, with no obligation.

Book a 60-minute session

Make every life-sciences decision evidence-led

Let us turn fragmented R&D, manufacturing and commercial data into traceable, decision-ready insight.

Talk to our pharma team